Paper4855751
Inhibition of DNA repair by the 1,3-bis(2-chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate.
Kann HE and 2 others. Cancer Res, 1974. Cited by 116 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of DNA repair by the 1,3-bis(2-chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate. Papers, record 4855751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4855751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of DNA repair by the 1,3-bis(2-chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carmustine | Major topic |
| Cyanates | Major topic |
| DNA Repair | Major topic |
| DNA, Neoplasm | Major topic |
| Leukemia L1210 | Major topic |
| Mustard Compounds | Major topic |
| Radiation Effects | Major topic |
| Animals | |
| Cells, Cultured | |
| Cycloheximide | |
| DNA, Single-Stranded | |
| Dactinomycin | |
| Depression, Chemical | |
| Ethylamines | |
| Hydroxyurea | |
| Isocyanates | |
| Mice |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38179340 | Continuous Extraction of 2-Chloroethyl isocyanate for 1-(2-chloroethyl)-3-cyclohexylurea Purification. | Chem Eng Process | 2023 | https://conductscience.org/library/papers/38179340 | PubMed |
| 25068797 | Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death. | PLoS One | 2014 | https://conductscience.org/library/papers/25068797 | PubMed |
| 19026985 | Inhibition of human DNA polymerase beta activity by the anticancer prodrug Cloretazine. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19026985 | PubMed |
| 6928639 | DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6928639 | PubMed |
| 6678867 | The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678867 | PubMed |
| 6088716 | Membrane and cytoplasmic changes in 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell lines. | J Neurooncol | 1983 | https://conductscience.org/library/papers/6088716 | PubMed |
| 2564000 | H2-antagonists and carmustine. | J Cancer Res Clin Oncol | 1989 | https://conductscience.org/library/papers/2564000 | PubMed |
| 2191847 | Antineoplastic drugs in 1990. A review (Part II). | Drugs | 1990 | https://conductscience.org/library/papers/2191847 | PubMed |
| 2052560 | Selective activation of human heat shock gene transcription by nitrosourea antitumor drugs mediated by isocyanate-induced damage and activation of heat shock transcription factor. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/2052560 | PubMed |
| 502351 | [Effect of BCNU on glutathione metabolism in human blood cells]. | Klin Wochenschr | 1979 | https://conductscience.org/library/papers/502351 | PubMed |
| 479266 | The effects of 1-methyl-1-nitrosourea on the survival pattern of cycling and noncycling HeLa cells. | J Cancer Res Clin Oncol | 1979 | https://conductscience.org/library/papers/479266 | PubMed |
| 393428 | Mutagenic effects of some anticancer antibiotics. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/393428 | PubMed |
| 195411 | The combined modality approach in the treatment of inoperable small-cell anaplastic carcinoma of the lung. | Z Krebsforsch Klin Onkol Cancer Res Clin Oncol | 1977 | https://conductscience.org/library/papers/195411 | PubMed |
| 136102 | Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential. | Z Krebsforsch Klin Onkol Cancer Res Clin Oncol | 1976 | https://conductscience.org/library/papers/136102 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4855751
GET https://conductscience.org/api/papers/v1/4855751/authors